Displaying items tagged: Hopen Life Science Ventures
Pharma spinoff started in Kzoo mulls IPO
A drug developer rooted in Southwest Michigan and backed by investors across the region may pursue an initial public stock offering that could net up to $86.2 million to support further development and commercialization.
Michigan VC ‘very healthy’ despite decline in out-of-state capital
In securing a $40 million investment, Cirius Therapeutics Inc. illustrates a fundamental change that occurred in Michigan’s venture capital sector over the last decade.
Kalamazoo biotech raises $40 million to develop new drug
KALAMAZOO — A $40 million venture capital investment in a company spun out of a Kalamazoo-based drug development firm comes with a new executive management team based across the country.
Kalamazoo drug developer lands $40M investment, moving office to San Diego
A company that spun out early last year from a Kalamazoo drug developer plans to move its office to San Diego, Calif. after securing $40 million in new venture capital funding.
Proposed $100 million public-private partnership would seed new Michigan VC funds
The trade group for venture capitalists in Michigan wants to form a $100 million fund to match millions in private capital with public investment.
